Table of Contents
ISRN Veterinary Science
Volume 2011, Article ID 584342, 5 pages
http://dx.doi.org/10.5402/2011/584342
Research Article

Disposition Kinetic of Moxifloxacin following Intravenous, Intramuscular, and Subcutaneous Administration in Goats

1Department of Pharmacology and Toxicology, College of Veterinary Science and Animal Husbandry, Junagadh Agricultural University, Junagadh 362 001, Gujarat State, India
2Department of Pharmacology and Toxicology, College of Veterinary Science and Animal Husbandry, Sardarkrushinagar Dantiwada Agricultural University, Sardarkrushinagar 385506, Dantiwada, India

Received 5 November 2011; Accepted 20 December 2011

Academic Editor: I. Nsahlai

Copyright © 2011 Harshad B. Patel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. K. Bhanot, M. Singh, and N. R. Chatterjee, “The chemical and biological aspects of fluoroquinolones: reality and dreams,” Current Pharmaceutical Design, vol. 7, no. 5, pp. 311–335, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Krasemann, J. Meyer, and G. Tillotson, “Evaluation of the clinical microbiology profile of moxifloxacin,” Clinical Infectious Diseases, vol. 32, supplement 1, pp. S51–S63, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. K. V. I. Rolston, S. Frisbee-Hume, B. LeBlanc, H. Streeter, and D. H. Ho, “In vitro antimicrobial activity of moxifloxacin compared to other quinolones against recent clinical bacterial isolates from hospitalized and community-based cancer patients,” Diagnostic Microbiology and Infectious Disease, vol. 47, no. 2, pp. 441–449, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Goudah and S. Hasabelnaby, “Pharmacokinetics and bioavailability of moxifloxacin in calves following different routes of administrations,” Chemotherapy, vol. 56, no. 1, pp. 26–31, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. C. M. Cárceles, L. Villamayor, E. Escudero, P. Marín, and E. Fernández-Varón, “Pharmacokinetics and milk penetration of moxifloxacin after intramuscular administration to lactating goats,” The Veterinary Journal, vol. 173, no. 2, pp. 452–455, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Fernández-Varón, L. Villamayor, E. Escudero, A. Espuny, and C. M. Cárceles, “Pharmacokinetics and milk penetration of moxifloxacin after intravenous and subcutaneous administration to lactating goats,” The Veterinary Journal, vol. 172, no. 2, pp. 302–307, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. C. M. Cárceles, E. Escudero, E. Fernández-Varón, and P. Marín, “Pharmacokinetics after intravenous, intramuscular and subcutaneous administration of moxifloxacin in sheep,” The Veterinary Journal, vol. 180, no. 3, pp. 343–347, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Goudah, “Disposition kinetics of moxifloxacin in lactating ewes,” The Veterinary Journal, vol. 178, no. 2, pp. 282–287, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. A. M. Abd El-Aty, A. Goudah, S. S. Shah, H. C. Shin, M. Shimoda, and J. H. Shim, “Pharmacokinetic variables of moxifloxacin in healthy male camels following intravenous and intramuscular administration,” Journal of Veterinary Pharmacology and Therapeutics, vol. 30, no. 6, pp. 586–591, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Y. Gardner, J. L. Davis, S. L. Jones et al., “Moxifloxacin pharmacokinetics in horses and disposition into phagocytes after oral dosing,” Journal of Veterinary Pharmacology and Therapeutics, vol. 27, no. 1, pp. 57–60, 2004. View at Google Scholar · View at Scopus
  11. S. K. Sharma and R. Pathania, “Pharmacokinetics of moxifloxacin in buffalo calves after single subcutaneous administration,” Indian Journal of Animal Sciences, vol. 80, no. 6, pp. 512–515, 2010. View at Google Scholar · View at Scopus
  12. E. Fernández-Varón, M. J. Bovaira, A. Espuny, E. Escudero, D. Vancraeynest, and C. M. Cárceles, “Pharmacokinetic-pharmacodynamic integration of moxifloxacin in rabbits after intravenous, intramuscular and oral administration,” Journal of Veterinary Pharmacology and Therapeutics, vol. 28, no. 4, pp. 343–348, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Goudah, “Pharmacokinetics and tissue residues of moxifloxacin in broiler chickens,” British Poultry Science, vol. 50, no. 2, pp. 251–258, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. H. M. Siefert, A. Domdey-Bette, K. Henninger, F. Hucke, C. Kohlsdorfer, and H. H. Stass, “Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: a comparison in humans and other mammalian species,” Journal of Antimicrobial Chemotherapy, vol. 43, pp. 69–76, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Gibaldi and D. Perrier, Non Compartmental Analysis Based on Statistical Moment Theory. Pharmacokinetics, Marcel Dekker, New York, NY, USA, 2nd edition, 1982.
  16. H. Lode, K. Borner, and P. Koeppe, “Pharmacodynamics of fluoroquinolones,” Clinical Infectious Diseases, vol. 27, no. 1, pp. 33–39, 1998. View at Google Scholar · View at Scopus
  17. C. H. Nightingale, E. M. Grant, and R. Quintiliani, “Pharmacodynamics and pharmacokinetics of levofloxacin,” Chemotherapy, vol. 46, supplement 1, pp. 6–14, 2000. View at Google Scholar · View at Scopus
  18. R. D. Walker, “The use of fluoroquinolones for companion animal antimicrobial therapy,” Australian Veterinary Journal, vol. 78, no. 2, pp. 84–90, 2000. View at Google Scholar · View at Scopus